Thermo Fisher Scientific (TMO) Interest & Investment Income (2009 - 2026)

Thermo Fisher Scientific (TMO) has 15 years of Interest & Investment Income data on file, last reported at $233.0 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income rose 14.78% year-over-year to $233.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 2.0% YoY), and the FY2025 full-year result was $993.0 million, down 7.88% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $233.0 million, down from $258.0 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $309.0 million in Q4 2023 and bottomed at $18.0 million in Q2 2022.
• A 5-year average of $203.2 million and a median of $233.0 million in 2026 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income soared 1263.64% in 2022 and dropped 27.24% in 2025, its largest moves.
• Tracing TMO's Interest & Investment Income over 5 years: stood at $150.0 million in 2022, then surged by 106.0% to $309.0 million in 2023, then fell by 26.54% to $227.0 million in 2024, then gained by 13.66% to $258.0 million in 2025, then declined by 9.69% to $233.0 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $233.0 million, $258.0 million, and $234.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison